Article
Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 May 2011
Hervé Avet-Loiseau, Florence Magrangeas, Philippe Moreau, Michel Attal, Thierry Facon, Kenneth Anderson, Jean-Luc Harousseau, Nikhil Munshi, Stéphane Minvielle
Abstract excerpt
Multiple myeloma (MM) is characterized by a significant heterogeneity at the molecular level. The first level is the chromosomal one. Although cytogenetics is difficult to assess in MM, patients can be divided into two categories: hyperdiploidy and non-hyperdiploidy (about half in each group). Using molecular cytogenetic techniques, several subgroups of patients are identified, particularly on the basis of 14q32...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
